Literature DB >> 27446477

Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particles.

Junko Maeda1, Ian M Cartwright1, Jeremy S Haskins1, Yoshihiro Fujii2, Hiroshi Fujisawa3, Hirokazu Hirakawa4, Mitsuru Uesaka3, Hisashi Kitamura5, Akira Fujimori4, Douglas H Thamm6, Takamitsu A Kato1.   

Abstract

Heavy ions, characterized by high linear energy transfer (LET) radiation, have advantages compared with low LET protons and photons in their biological effects. The application of heavy ions within veterinary clinics requires additional background information to determine heavy ion efficacy. In the present study, comparison of the cell-killing effects of photons, protons and heavy ions was investigated in canine osteosarcoma (OSA) cells in vitro. A total of four canine OSA cell lines with various radiosensitivities were irradiated with 137Cs gamma-rays, monoenergetic proton beams, 50 keV/µm carbon ion spread out Bragg peak beams and 200 keV/µm iron ion monoenergetic beams. Clonogenic survival was examined using colony-forming as says, and relative biological effectiveness (RBE) values were calculated relative to gamma-rays using the D10 value, which is determined as the dose (Gy) resulting in 10% survival. For proton irradiation, the RBE values for all four cell lines were 1.0-1.1. For all four cell lines, exposure to carbon ions yielded a decreased cell survival compared with gamma-rays, with the RBE values ranging from 1.56-2.10. Iron ions yielded the lowest cell survival among tested radiation types, with RBE values ranging from 3.51-3.69 observed in the three radioresistant cell lines. The radiosensitive cell line investigated demonstrated similar cell survival for carbon and iron ion irradiation. The results of the present study suggest that heavy ions are more effective for killing radioresistant canine OSA cells when compared with gamma-rays and protons. This markedly increased efficiency of cell killing is an attractive reason for utilizing heavy ions for radioresistant canine OSA.

Entities:  

Keywords:  canine osteosarcoma; carbon-ion; photon; relative biological effectiveness

Year:  2016        PMID: 27446477      PMCID: PMC4950660          DOI: 10.3892/ol.2016.4808

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Repair of DNA double-strand breaks and cell killing by charged particles.

Authors:  K Eguchi-Kasai; M Murakami; H Itsukaichi; K Fukutsu; F Yatagai; T Kanai; H Ohara; K Sato
Journal:  Adv Space Res       Date:  1998       Impact factor: 2.152

2.  LET and ion species dependence for cell killing in normal human skin fibroblasts.

Authors:  Chizuru Tsuruoka; Masao Suzuki; Tatsuaki Kanai; Kazunobu Fujitaka
Journal:  Radiat Res       Date:  2005-05       Impact factor: 2.841

Review 3.  Particle radiation therapy using proton and heavier ion beams.

Authors:  Daniela Schulz-Ertner; Hirohiko Tsujii
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

Review 4.  Radiation therapy for canine appendicular osteosarcoma.

Authors:  A Coomer; J Farese; R Milner; J Liptak; N Bacon; D Lurie
Journal:  Vet Comp Oncol       Date:  2009-03       Impact factor: 2.613

Review 5.  Recent advances in the biology of heavy-ion cancer therapy.

Authors:  Nobuyuki Hamada; Tatsuhiko Imaoka; Shin-ichiro Masunaga; Toshiyuki Ogata; Ryuichi Okayasu; Akihisa Takahashi; Takamitsu A Kato; Yasuhiko Kobayashi; Takeo Ohnishi; Koji Ono; Yoshiya Shimada; Teruki Teshima
Journal:  J Radiat Res       Date:  2010       Impact factor: 2.724

6.  Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams.

Authors:  E A Blakely; C A Tobias; T C Yang; K C Smith; J T Lyman
Journal:  Radiat Res       Date:  1979-10       Impact factor: 2.841

7.  Particle irradiation suppresses metastatic potential of cancer cells.

Authors:  Toshiyuki Ogata; Teruki Teshima; Kazufumi Kagawa; Yoshio Hishikawa; Yutaka Takahashi; Atsuko Kawaguchi; Yuko Suzumoto; Kumie Nojima; Yoshiya Furusawa; Nariaki Matsuura
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

8.  Proton therapy in Japan.

Authors:  H Tsunemoto; S Morita; T Ishikawa; S Furukawa; K Kawachi; T Kanai; H Ohara; T Kitagawa; T Inada
Journal:  Radiat Res Suppl       Date:  1985

Review 9.  Comparative biology of human and canine osteosarcoma.

Authors:  F Mueller; B Fuchs; B Kaser-Hotz
Journal:  Anticancer Res       Date:  2007 Jan-Feb       Impact factor: 2.480

10.  Genomic instability and telomere fusion of canine osteosarcoma cells.

Authors:  Junko Maeda; Charles R Yurkon; Hiroshi Fujisawa; Masami Kaneko; Stefan C Genet; Erica J Roybal; Garrett W Rota; Ethan R Saffer; Barbara J Rose; William H Hanneman; Douglas H Thamm; Takamitsu A Kato
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more
  5 in total

1.  Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells.

Authors:  Shigeaki Sunada; Ian M Cartwright; Hirokazu Hirakawa; Akira Fujimori; Mitsuru Uesaka; Takamitsu A Kato
Journal:  Oncol Lett       Date:  2017-04-21       Impact factor: 2.967

2.  Comparative oncology approach to drug repurposing in osteosarcoma.

Authors:  Alejandro Parrales; Peter McDonald; Megan Ottomeyer; Anuradha Roy; Frank J Shoenen; Melinda Broward; Tyce Bruns; Douglas H Thamm; Scott J Weir; Kathleen A Neville; Tomoo Iwakuma; Joy M Fulbright
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

3.  DNA Repair Deficient Chinese Hamster Ovary Cells Exhibiting Differential Sensitivity to Charged Particle Radiation under Aerobic and Hypoxic Conditions.

Authors:  Ian M Cartwright; Cathy Su; Jeremy S Haskins; Victoria A Salinas; Shigeaki Sunada; Hao Yu; Mitsuru Uesaka; Hirokazu Hirakawa; David J Chen; Akira Fujimori; Takamitsu A Kato
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

4.  Palmitoyl ascorbic acid 2-glucoside has the potential to protect mammalian cells from high-LET carbon-ion radiation.

Authors:  Alexis H Haskins; Dylan J Buglewicz; Hirokazu Hirakawa; Akira Fujimori; Yasushi Aizawa; Takamitsu A Kato
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

5.  High LET Radiation Overcomes In Vitro Resistance to X-Rays of Chondrosarcoma Cell Lines.

Authors:  Francois Chevalier; Dounia Houria Hamdi; Charlotte Lepleux; Mihaela Temelie; Anaïs Nicol; Jean Baptiste Austry; Paul Lesueur; Guillaume Vares; Diana Savu; Tetsuo Nakajima; Yannick Saintigny
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.